Lykis Limited (LYKISLTD) Fair Value & Analysis
Consumer Defensive · IN · Market cap ₹862M
Strengths
Risks
Fair value as of: Aug 13, 2026
From 15 valuation models · updated 9 days ago
Below-average quality, currently priced close to our fair value.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Our model range runs from ₹42.51 (bear) to ₹70.85 (bull), base ₹56.68. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 47/100 (below-average quality) with high evidence: the data supports the verdict.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range ₹23.05 – ₹131.95 · fair‑value band ₹42.51 – ₹70.85 · the ₹51.97 price screens below the ₹56.68 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Lykis Limited (LYKISLTD) currently trades at ₹51.97, while our model-based Fair Value estimate is ₹56.68, implying the stock looks roughly 9.1% fairly valued today. The Quality Score stands at 47/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Lykis Limited generated revenue of ₹3.9B at a net margin of 1.7%. Revenue grew 136.6% year over year. It earns a return on equity of 17.3%. Net debt stands at ₹978M. Fundamentals as of Aug 13, 2026
Our scenario range runs from ₹42.51 (bear case) to ₹70.85 (bull case); at ₹51.97, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 16% below its 52-week high and 78% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -38% fair-value upside, at 9%, LYKISLTD screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 15 models by family
Widest divergence: DCF Models (₹107.93) versus Asset-Based (₹14.11). Highest evidence: ROIC Compounder (72).
Notify me when LYKISLTD reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 43 · Market factors (momentum, volatility) 59
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Lykis Limited engages in the fast moving consumer goods (FMCG) business in India and internationally. The company provides personal care products including skin care products, such as creams, face wash, body oil, lotion, shower gel, masks, face and body scrub, hair removal cream, petroleum jelly, body butter, talc, intimate wash, petroleum jelly, and hand …
Full company description
Lykis Limited engages in the fast moving consumer goods (FMCG) business in India and internationally. The company provides personal care products including skin care products, such as creams, face wash, body oil, lotion, shower gel, masks, face and body scrub, hair removal cream, petroleum jelly, body butter, talc, intimate wash, petroleum jelly, and hand wash; hair care products comprising shampoo, spray, conditioner, base cream, hair food and relaxer, oil, detox mask, cleansing liquid, hair colour and milk, pomade, and gels; toothpaste; soaps; deodorant, perfume, and body mist; and baby cream, oil, shampoo, talc, wipes, and diaper. It also offers FMCG products, including biscuits and cookies; confectionery, such as candy, lollipops, and toffees; commodity products comprising hot pots, stock pots, utensils, footwear, liquor, and others; and other OTC products. The company provides its products under the Lykis, H&H, Rox, Bonita, Monami, Special, Lykon, Bentol, Stylo, Bon Fami, Calmon, Bon Dejeuner, Mellar, Bom Dia, Blue Fins, Bon Appetit, Senhorita, Polo Star, Leopard, Elephant, Carnoba, Classic, Maria, Spectra, Flite, Bahamas, Sparx, Metro, Cipro, Para, Dextrose and Water for Injection, Davigra, Dermogerme, A-DEM, Candicyl, Rectostop-HC, Nystatine, and Davimov brands. It also exports its products. Lykis Limited was formerly known as Greenline Tea & Exports Limited and changed its name to Lykis Limited in July 2012. The company was incorporated in 1984 and is headquartered in Mumbai, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Lykis Limited reported revenue of ₹3.9B in FY2026 versus ₹3.2B in FY2022, a compound +4.7%/yr. Reported net income was ₹64.8M in FY2026, compounding +27.9%/yr from FY2022.
Watch LYKISLTD: get an alert when its fair value changes →
Peer Group
Household & Personal Products · 250 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Household & Personal Products median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | $144.26 | $108.16 | -25% |
| Unilever PLC ULN | 1,080 MXN | 973.58 MXN | -10% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,015 | ₹789.46 | -61% |
| Essity AB ESSITYA | kr 273.00 | kr 250.02 | -8% |
| Godrej Consumer Products Limited GODREJCP | ₹936.90 | ₹367.64 | -61% |
| Marico Limited MARICO | ₹853.40 | ₹233.20 | -73% |
| APR Co 278470 | 396,500 KRW | 137,521 KRW | -65% |
| Dabur India Limited DABUR | ₹411.25 | ₹175.59 | -57% |
| PT Unilever Indonesia Tbk UNVR | 1,795 IDR | 1,928 IDR | +7% |
| Amorepacific Corporation 090430 | 135,700 KRW | 84,785 KRW | -38% |
Compare Lykis Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Lykis Limited (LYKISLTD) overvalued or undervalued?
What is the fair value of LYKISLTD?
What is the quality score of LYKISLTD?
What is the revenue of Lykis Limited (LYKISLTD)?
What is the net profit margin of LYKISLTD?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Lykis Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.